Company Search:
Advanced Search
Sponsored Links
Neptune Technologies & Bioressources Inc Company Snapshot
Neptune Technologies & Bioressources Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Neptune Technologies & Bioressources Inc with three other miscellaneous service companies in North America: Pharmaxis Ltd of the United States (2016 sales of $13.50 million of which 80% was Bronchitol and Aridol), Bioanalytical Systems, Inc. of the United States ($20.44 million ), and Vernalis Plc which is also based in the United States ($17.68 million of which 67% was Collaborative).

Sales Analysis. During the year ended February of 2016, sales at Neptune Technologies & Bioressources Inc were C$22.63 million (US$17.06 million). This is an increase of 50.2% versus 2015, when the company's sales were C$15.07 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Neptune Technologies & Bioressources Inc
  Stock Performance Chart for Neptune Technologies & Bioressources Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/20/2017): 1.42
(Figures in Canadian Dollars)
1 Week 1.4%   13 Weeks 10.1%  
4 Weeks -12.3%   52 Weeks -13.9%  
Neptune Technologies & Bioressources Inc Key Data:
  Ticker: NEPT Country: Canada
  Exchanges: VEN Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 22,632,442
(Year Ending Jan 2017).
Employees: 78
  Currency: Canadian Dollars Market Cap: 110,682,678
  Fiscal Yr Ends: February Shares Outstanding: 77,945,548
  Share Type: Closely Held Shares: 18,999,584
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.